Anti-GPNMB antibody [EPR22011-11]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal GPNMB antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 6 publications.
View Alternative Names
HGFIN, NMB, UNQ1725/PRO9925, GPNMB, Transmembrane glycoprotein NMB, Hematopoietic growth factor inducible neurokinin-1 type
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GPNMB antibody [EPR22011-11] (AB222109)
Immunohistochemical analysis of paraffin-embedded human melanoma tissue labeling GPNMB with ab222109 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Positive staining in tumor cells of human melanoma. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GPNMB antibody [EPR22011-11] (AB222109)
Immunohistochemical analysis of paraffin-embedded human colonic carcinoma tissue labeling GPNMB with ab222109 at 1/1000 dilution, followed by aGoat Anti-Rabbit IgG H&L (HRP) Ready to use. Positive staining on stroma cells of human colonic carcinoma. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-GPNMB antibody [EPR22011-11] (AB222109)
Blocking/Dilution buffer : 5% NFDM/TBST.
The molecular mass observed is consistent with what has been described in the literature (PMID : 19320736).
Negative control : HeLa (PMID : 20056711)
All lanes:
Western blot - Anti-GPNMB antibody [EPR22011-11] (ab222109) at 1/1000 dilution
Lane 1:
SK-MEL-28 (human malignant melanoma) whole cell lysate at 10 µg
Lane 2:
SK-MEL-2 (Human skin malignant melanoma) whole cell lysate at 10 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 64 kDa
Observed band size: 120 kDa,95 kDa
false
Exposure time: 81s
- WB
Lab
Western blot - Anti-GPNMB antibody [EPR22011-11] (AB222109)
ab222109 was shown to react with GPNMB in wild-type U-87 MG cells in Western blot with loss of signal observed in a GPNMB siRNA knockdown cell line. Cell lysates from wild-type U-87 MG transfected with either scrambled siRNA or GPNMB siRNA were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab222109 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-GPNMB antibody [EPR22011-11] (ab222109) at 1/1000 dilution
Lane 1:
Wild-type U-87 MG transfected with scrambled siRNA control lysate at 60 µg
Lane 2:
U-87 MG transfected with siRNA specifically targeting GPNMB cell lysate at 60 µg
false
Related conjugates and formulations (1)
-
Anti-GPNMB antibody [EPR22011-11] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GPNMB plays versatile roles in promoting cell growth differentiation and repair. It is involved in processes like tissue regeneration possibly due to its role in cell adhesion and migration. The protein also partakes in osteoclast differentiation and bone resorption therefore linking to skeletal homeostasis. GPNMB forms part of a broader protein complex at the cellular junctions interacting with integrins to mediate its functions.
Pathways
GPNMB features prominently in osteoclastogenesis and melanoma metastasis pathways. It cooperates with RANKL an important protein in bone metabolism by influencing osteoclast differentiation and activation. In the context of melanoma GPNMB's action in pathways may enhance tumor proliferation and invasion possibly interacting with signaling molecules like AKT or ERK although the specifics remain actively researched.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Cancer research 83:3783-3795 PubMed37668527
2023
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 102:e32889 PubMed36862875
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology research 11:405-420 PubMed36652202
2023
Applications
Unspecified application
Species
Unspecified reactive species
Analytical cellular pathology (Amsterdam) 2022:9303081 PubMed36090016
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical immunology 42:1638-1652 PubMed35829840
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 23:36 PubMed34966452
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com